• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparing ranibizumab with bevacizumab.

作者信息

Biswas Partha, Sengupta Subhrangshu, Choudhary Ruby, Home Subhankar, Paul Ajoy, Sinha Sourav

出版信息

Ophthalmology. 2011 Mar;118(3):600-600.e2. doi: 10.1016/j.ophtha.2010.10.027.

DOI:10.1016/j.ophtha.2010.10.027
PMID:21376243
Abstract
摘要

相似文献

1
Comparing ranibizumab with bevacizumab.雷珠单抗与贝伐单抗的比较。
Ophthalmology. 2011 Mar;118(3):600-600.e2. doi: 10.1016/j.ophtha.2010.10.027.
2
Intravitreal bevacizumab for parapapillary choroidal neovascularization due to exudative age-related macular degeneration.玻璃体内注射贝伐单抗治疗渗出性年龄相关性黄斑变性所致视乳头旁脉络膜新生血管
Acta Ophthalmol. 2011 Feb;89(1):e105-7. doi: 10.1111/j.1755-3768.2009.01820.x.
3
The as-needed treatment strategy for choroidal neovascularization: a feedback-based treatment system.脉络膜新生血管的按需治疗策略：一种基于反馈的治疗系统。
Am J Ophthalmol. 2009 Jul;148(1):1-3. doi: 10.1016/j.ajo.2009.04.010.
4
A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.雷珠单抗治疗初治的年龄相关性黄斑变性继发非黄斑中心凹脉络膜新生血管的1年回顾性研究
Retina. 2009 Nov-Dec;29(10):1444-9. doi: 10.1097/IAE.0b013e3181ae712d.
5
Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.玻璃体内注射贝伐单抗治疗年龄相关性黄斑变性中心凹下脉络膜新生血管：泛美视网膜协作研究组12个月随访结果
Retina. 2008 Nov-Dec;28(10):1387-94. doi: 10.1097/IAE.0b013e3181884ff4.
6
Short-term effectiveness of intravitreal bevacizumab versus ranibizumab injections for patients with neovascular age-related macular degeneration.玻璃体内注射贝伐单抗与雷珠单抗治疗新生血管性年龄相关性黄斑变性的短期疗效。
Retina. 2009 Oct;29(9):1235-41. doi: 10.1097/IAE.0b013e3181b20eed.
7
Intravitreal bevacizumab for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.玻璃体内注射贝伐单抗治疗年龄相关性黄斑变性伴色素上皮脱离的隐匿性脉络膜新生血管
Acta Ophthalmol Scand. 2006 Oct;84(5):713-4. doi: 10.1111/j.1600-0420.2006.00759.x.
8
Intravitreal bevacizumab.玻璃体内注射贝伐单抗。
Ophthalmology. 2007 Feb;114(2):400; author reply 400-1. doi: 10.1016/j.ophtha.2006.10.002.
9
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.雷珠单抗玻璃体腔内注射可变剂量方案治疗新生血管性年龄相关性黄斑变性：PrONTO研究的第2年
Am J Ophthalmol. 2009 Jul;148(1):43-58.e1. doi: 10.1016/j.ajo.2009.01.024. Epub 2009 Apr 18.
10
Intravitreal bevacizumab for peripapillary classic subretinal neovascularization.玻璃体内注射贝伐单抗治疗视乳头周围典型性视网膜下新生血管形成
Acta Ophthalmol Scand. 2007 May;85(3):340-1. doi: 10.1111/j.1600-0420.2006.00832.x.

引用本文的文献

1
Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis.抗血管内皮生长因子治疗视网膜疾病：系统评价和荟萃分析。
BMJ Open. 2019 May 28;9(5):e022031. doi: 10.1136/bmjopen-2018-022031.
2
Mortality associated with bevacizumab intravitreal injections in age-related macular degeneration patients after acute myocardial infarct: a retrospective population-based survival analysis.年龄相关性黄斑变性患者急性心肌梗死后玻璃体内注射贝伐单抗相关的死亡率：一项基于人群的回顾性生存分析。
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):651-663. doi: 10.1007/s00417-018-3917-9. Epub 2018 Feb 10.
3
Bevacizumab and ranibizumab for neovascular age-related macular degeneration: an updated meta-analysis of randomised clinical trials.
贝伐单抗和雷珠单抗治疗新生血管性年龄相关性黄斑变性：随机临床试验的最新荟萃分析
Graefes Arch Clin Exp Ophthalmol. 2014 Oct;252(10):1529-37. doi: 10.1007/s00417-014-2764-6. Epub 2014 Aug 22.
4
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review.玻璃体内注射贝伐单抗单药治疗成人眼科疾病的安全性：系统评价
BMJ Open. 2014 Jul 17;4(7):e005244. doi: 10.1136/bmjopen-2014-005244.
5
Changing paradigms of anti-VEGF in the Indian scenario.改变印度抗 VEGF 治疗模式。
Indian J Ophthalmol. 2014 Jan;62(1):88-92. doi: 10.4103/0301-4738.126189.
6
FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity.FUSION 方案：雷珠单抗治疗初治渗出型年龄相关性黄斑变性且基线视力较好的患者。
Graefes Arch Clin Exp Ophthalmol. 2012 Dec;250(12):1737-44. doi: 10.1007/s00417-012-2009-5. Epub 2012 Apr 15.